Metagenomi Technologies, LLC Stock Forum

Another good stretch. In the end, we gained 2.42% this week.
Top winners for me were
$Vertiv Holdings (VRT.US)$
$NVIDIA (NVDA.US)$
$Esperion Therapeutics (ESPR.US)$
$ACM Research (ACMR.US)$
$Avenue Therapeutics (ATXI.US)$
My top losers were:
$Metagenomi Technologies, LLC (MGX.US)$ - Sued for securities fraud, lied about relationship with Moderna in IPO last Feb.
$e.l.f. Beauty (ELF.US)$ - Continued sell off due to Buffet's investment in Ulta Beauty and overall Old Money ignorance to new...

$Metagenomi Technologies, LLC (MGX.US)$ $Lantronix (LTRX.US)$
$Fate Therapeutics (FATE.US)$
$Navitas Semiconductor (NVTS.US)$
Opened up some positions on these today.
Increased $Rivian Automotive (RIVN.US)$ , $X4 Pharmaceuticals (XFOR.US)$
Took profit on $FTC Solar (FTCI.US)$ , $GigaCloud Technology (GCT.US)$ and $Aurora Innovation (AUR.US)$
I'll be back in GCT and AUR for sure.
Still looking at $Spero Therapeutics (SPRO.US)$ and $Acacia Research (ACTG.US)$ too.
Exciting day for dips!

$Metagenomi Technologies, LLC (MGX.US)$
Metagenomi Announces Preclinical Data for Lead Hemophilia A Program Demonstrating Durable Factor VIII (FVIII) Activity Levels through Twelve Months
Metagenomi (Nasdaq: MGX) has announced promising 12-month durability data for its lead hemophilia A program, MGX-001.
The preclinical study in nonhuman primates (NHPs) demonstrated durable Factor VIII (FVIII) activity levels through twelve months, with two NHPs showing normal/near-normal levels (82% and 41%...

$Metagenomi Technologies, LLC (MGX.US)$
Metagenomi Presents AI-Enabled Advancements of SMART Editing Platform at the Cold Spring Harbor Laboratory CRISPR Frontiers Conference
Metagenomi (Nasdaq: MGX) presented advancements in its AI-enabled SMART Editing Platform at the CRISPR Frontiers Conference. The company showcased AI-generated compact SMART nucleaseswith robust genome editing activity in mammalian cells. These tools, fitting within size-constrained delivery technologies, may ena...